Subscribe: Market Wire - Medical and Healthcare: Dentistry
http://img.marketwire.com/rss/mwMHDE.rss
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
agreement  announces  axim  company  jun  kane biotech  loan  marketwired jun  marketwired  otc pink  otc  products  solutions  today  week 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Dentistry

Marketwired - Dentistry



Marketwired - Dentistry



Last Build Date: Tue, 27 Jun 2017 19:06:47 EDT

Copyright: Copyright: (C) Marketwired
 



Kane Biotech Announces Closing of Loan Transaction

Tue, 27 Jun 2017 18:16:39 EDT

WINNIPEG, MANITOBA--(Marketwired - June 27, 2017) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech") today announced that it has received a loan (the "Loan") in the amount of $400,000 from Individual Investment Corporation, an arm's length third-party lender (the "Lender"). The Loan bears interest at 12% per annum and is repayable after two months. The Corporation has also paid a one-time document review fee of $8,000 to the Lender as additional consideration for the provision of the Loan to the Company.




AXIM Biotechnologies (OTCQB: AXIM) Takes on Opioid Epidemic with New Patent -- SECFilings.com

Tue, 27 Jun 2017 09:30:00 EDT

AXIM is a major investment of Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company




Profitable Developments, Inc., Provides Corporate Update

Tue, 27 Jun 2017 08:30:00 EDT

NEW YORK, NY--(Marketwired - Jun 27, 2017) - Profitable Developments, Inc. (OTC PINK: PRDL) is pleased to announce a new division for the company, with a strategic focus on the CBD Health Market. Presently under evaluation are acquisition and development opportunities of products and operations in this expanding market sector.




Therapeutic Solutions Subsidiary, SandBox Dental Labs, files 510(k) with FDA

Mon, 26 Jun 2017 09:00:00 EDT

Company Seeks Market Clearance for Oral Appliance To Treat Moderate Obstructive Sleep Apnea




Sirrus Corp. Highlights Opportunities for RelifyTIME Verification Services

Mon, 26 Jun 2017 07:00:00 EDT

JOHNS CREEK, GA--(Marketwired - Jun 26, 2017) - Sirrus Corp. ("Sirrus" or the "Company") (OTC PINK: SRUP), an emerging cybersecurity solutions provider, today provided this discussion regarding business development opportunities for the Company's Time Verification Services Strategic Partnership with RelifyTIME LLC ("RelifyTIME").




DHL CARE Awards: Three major air carriers named winners at the Life Sciences Healthcare Conference in Singapore

Thu, 22 Jun 2017 22:12:46 EDT

SINGAPORE--(Marketwired - Jun 22, 2017) -




Alpha Pro Tech, Ltd. Announces Additional $2 Million Expansion to Share Repurchase Program

Thu, 22 Jun 2017 16:15:00 EDT

NOGALES, AZ--(Marketwired - Jun 22, 2017) - Alpha Pro Tech, Ltd. (NYSE MKT: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced that its Board of Directors has authorized a $2.0 million expansion of the Company's existing share repurchase program.




ECPO-Subsidiary Immunotech Laboratories Enters Final Step of Full Commercialization by the BDA post Phase 3 Approval of ITV-1 for HIV/AIDS; Also Announces Issuance of Distribution Agreement for the Ukraine

Thu, 22 Jun 2017 13:24:33 EDT

MONROVIA, CA--(Marketwired - Jun 22, 2017) - Eco Petroleum Solutions, Inc. ((OTC PINK: ECPO) or the "Company") announces that IMMB BG a subsidiary of Immunotech Laboratories, Inc., the Company's subsidiary, has issued an exclusive Distribution Agreement (the "Agreement") for the territory of the Ukraine to LLC Project Development and Implementation Centre Omega ("Omega"). The term of the agreement is for an initial ten-year period with an option to renew the agreement for an additional ten years. The Agreement establishes a price of EUR 3,300 (Euros) per one 8-week cycle of injections or 16 vials. The treatment protocol requires two 8-week cycles of injections administered twice a week with a one-week break between cycles. The ITV-1 treatment will be administered with a combination of different variations of Protease Inhibitors used in the treatment of HIV/AIDS.




ORHub (ORHB) Sets Exercise Price for its Series B and D Warrants

Wed, 21 Jun 2017 10:50:28 EDT

NEWPORT BEACH, CA--(Marketwired - Jun 21, 2017) - ORHub, Inc. (OTC: ORHB), a cloud-based medical software company established as the Operating Room Hub for data and analytics, today announces a $0.50 exercise price for all the Company's Series B & D Warrants.